Listed by the USPTO as STONE, RACHAEL SOJIN
Tech Center 3600 • Art Units: 3681 3682 3686
This examiner grants 55% of resolved cases
STONE, RACHAEL SOJIN works in Tech Center 3600 and Art Unit 3681. The profile records 105 resolved cases and an allowance rate of 55.2%. The interview lift is 21.0%, and the median time to allowance is 1154 days. The record shows a majority allowance outcome and a positive interview association, but its case base is limited compared with a large established docket.
The represented companies are Cerner Innovation Inc., Fujifilm Corporation, and University of Florida Research Foundation Inc. The listed firms are Invoke, STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C., and ALSTON & BIRD LLP. Counsel can use the data for initial planning while treating matter-specific facts as important.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18552486 | PREDICTION OF POST-OPERATIVE PAIN USING HOSVD | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 18457331 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND INFORMATION PROCESSING PROGRAM | Non-Final OA | FUJIFILM Corporation |
| 18304372 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND INFORMATION PROCESSING PROGRAM | Non-Final OA | FUJIFILM CORPORATION |
| 18112118 | EVENT RATE ASSESSMENT | Non-Final OA | Cardiac Pacemakers, Inc. |
| 18822170 | DEPLOYMENT AND USE OF A CONTINUOUS ANALYTE MONITORING SYSTEM FOR IMPROVED PATIENT TREATMENT | Final Rejection | Abbott Diabetes Care Inc. |
| 18718077 | IMPROVED DIAGNOSIS AND TREATMENT SELECTION THROUGH TISSUE PROPERTY DETERMINATION USING BALLOONING, IMAGING AND DIGITAL TWINS | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18808124 | SEPSIS DIAGNOSIS AND PREDICTION | Final Rejection | Fujitsu Limited |
| 19298612 | BED EXIT PREDICTION BASED ON PATIENT BEHAVIOR PATTERNS | Non-Final OA | Hill-Rom Services, Inc. |
| 18153948 | SENSOR ERROR MITIGATION | Non-Final OA | MEDTRONIC MINIMED, INC. |
| 17950760 | PNEUMONIA READMISSION PREVENTION | Final Rejection | CERNER INNOVATION, INC. |
| 17733538 | PREDICTING GLYCOGEN STORAGE DISEASES (POMPE DISEASE) AND DECISION SUPPORT | Non-Final OA | CERNER INNOVATION, INC. |
| 17123520 | Opioid Use Disorder Predictor | Final Rejection | CERNER INNOVATION, INC. |
| 16154491 | FORECASTING UTERINE ACTIVITY | Non-Final OA | CERNER INNOVATION, INC. |
| 18997336 | REAL WORLD DATA BASED SUPPORT FOR GENERATING CLINICAL REPORTS | Non-Final OA | Smart Reporting GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy55.2% of resolved applications examined by Rachael Sojin Stone were allowed (105 resolved cases), compared with 26.4% across Art Unit 3681 over the last five years.
This examiner's interview lift is +21.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Rachael Sojin Stone took 1,154 days on average from filing to allowance.
Rachael Sojin Stone examines applications in Art Unit 3681 in Tech Center 3600 (Transportation, E-Commerce & Mechanical Systems).
